N/A
Completed N=2,014
Attain Success Clinical Trial
Source: ClinicalTrials.gov NCT00990964 ↗Enrolled (actual)
2,014
Serious AEs
2.7%
Results posted
Sep 2012
Primary outcomePrimary: Subjects Successfully Implanted With an Attain Family Left-heart Lead Using an Attain Family Delivery Catheter — 1802 participants
Summary
The purpose of the study is to assess lead implant success and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Subjects Successfully Implanted With an Attain Family Left-heart Lead Using an Attain Family Delivery Catheter |
1802 | — |
| PRIMARY Subjects Without a Left-heart Lead and Delivery Catheter Related Complication |
1895 | — |
Eligibility Criteria
Inclusion Criteria
- Subject is at least 18 years of age or older
- Subject will be implanted with Medtronic cardiac resynchronization therapy (CRT) device and Medtronic left heart lead utilizing (or attempting to utilize) Attain Family of delivery catheters. The implant procedure may include upgrades to CRT from implantable pulse generator (IPG) or implantable cardioverter-defibrillator (ICD).
Exclusion Criteria
- Subject is enrolled in a concurrent study with the exception of a study approved by the Medtronic Clinical Trial Leader prior to enrollment
- Subject has existing CRT system implanted or was previously implanted with a CRT system.
Data sourced from ClinicalTrials.gov (NCT00990964). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.